| Literature DB >> 28324104 |
Xian Xian1,2, Takayuki Sakurai1, Akiko Kamiyoshi1, Yuka Ichikawa-Shindo1, Megumu Tanaka1, Teruhide Koyama1, Hisaka Kawate1, Lei Yang3, Tian Liu1, Akira Imai1, Liuyu Zhai1, Kazutaka Hirabayashi1, Kun Dai1, Keiya Tanimura1, Teng Liu1, Nanqi Cui1, Kyoko Igarashi4, Akihiro Yamauchi4, Takayuki Shindo1.
Abstract
Neointimal hyperplasia is the primary lesion underlying atherosclerosis and restenosis after coronary intervention. We previously described the essential angiogenic function of the adrenomedullin (AM)-receptor activity-modifying protein (RAMP) 2 system. In the present study, we assessed the vasoprotective actions of the endogenous AM-RAMP2 system using a wire-induced vascular injury model. We found that neointima formation and vascular smooth muscle cell proliferation were enhanced in RAMP2+/- male mice. The injured vessels from RAMP2+/- mice showed greater macrophage infiltration, inflammatory cytokine expression, and oxidative stress than vessels from wild-type mice and less re-endothelialization. After endothelial cell-specific RAMP2 deletion in drug-inducible endothelial cell-specific RAMP2-/- (DI-E-RAMP2-/-) male mice, we observed markedly greater neointima formation than in control mice. In addition, neointima formation after vessel injury was enhanced in mice receiving bone marrow transplants from RAMP2+/- or DI-E-RAMP2-/- mice, indicating that bone marrow-derived cells contributed to the enhanced neointima formation. Finally, we found that the AM-RAMP2 system augmented proliferation and migration of endothelial progenitor cells. These results demonstrate that the AM-RAMP2 system exerts crucial vasoprotective effects after vascular injury and could be a therapeutic target for the treatment of vascular diseases.Entities:
Mesh:
Substances:
Year: 2017 PMID: 28324104 DOI: 10.1210/en.2016-1531
Source DB: PubMed Journal: Endocrinology ISSN: 0013-7227 Impact factor: 4.736